451 related articles for article (PubMed ID: 19173911)
21. Pancreatic liver metastases after curative resection combined with intraoperative radiation for pancreatic cancer.
Takamori H; Hiraoka T; Kanemitsu K; Tsuji T
Hepatogastroenterology; 2004; 51(59):1500-3. PubMed ID: 15362786
[TBL] [Abstract][Full Text] [Related]
22. Resectable pancreatic cancer: who really benefits from resection?
Barugola G; Partelli S; Marcucci S; Sartori N; Capelli P; Bassi C; Pederzoli P; Falconi M
Ann Surg Oncol; 2009 Dec; 16(12):3316-22. PubMed ID: 19707831
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
24. Analysis of long-term survivors after surgical resection for pancreatic cancer.
Han SS; Jang JY; Kim SW; Kim WH; Lee KU; Park YH
Pancreas; 2006 Apr; 32(3):271-5. PubMed ID: 16628082
[TBL] [Abstract][Full Text] [Related]
25. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with survival after surgical resection in Chinese patients with ductal adenocarcinoma of the pancreatic head.
Li Q; Gao C; Li H; Juzi JT; Chen H; Hao X
Dig Surg; 2008; 25(2):87-92. PubMed ID: 18362471
[TBL] [Abstract][Full Text] [Related]
27. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
[TBL] [Abstract][Full Text] [Related]
28. Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma.
Berger AC; Meszoely IM; Ross EA; Watson JC; Hoffman JP
Ann Surg Oncol; 2004 Jul; 11(7):644-9. PubMed ID: 15197014
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
[TBL] [Abstract][Full Text] [Related]
30. Retrospective evaluation of the influence of postoperative tumor marker status on survival and patterns of recurrence after surgery for pancreatic cancer based on RECIST guidelines.
Motoi F; Rikiyama T; Katayose Y; Egawa S; Unno M
Ann Surg Oncol; 2011 Feb; 18(2):371-9. PubMed ID: 20842460
[TBL] [Abstract][Full Text] [Related]
31. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
32. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
33. [Risk factors for recurrence and metastasis after radical anterior resection for rectal cancer].
Wu TC; Shao YF; Li JQ; Wu JX; Zhou ZX; Xu LB; Wang B
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):210-3. PubMed ID: 16721679
[TBL] [Abstract][Full Text] [Related]
34. [Results of resection for ductal adenocarcinoma of the pancreatic head].
Morin B; Chiche L; Salame E; Lebreton G; Rouleau V; Segol P
Ann Chir; 2006 Nov; 131(9):518-23. PubMed ID: 17045233
[TBL] [Abstract][Full Text] [Related]
35. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
37. [Postoperative recurrence-related factors of 125 patients with cT1-2N0 squamous cell carcinoma of the oral tongue].
Han JM; Wu GH; Zeng ZY; Chen FJ; Chen WK; Li H; Song M; Sun CZ
Ai Zheng; 2007 Jun; 26(6):661-5. PubMed ID: 17562277
[TBL] [Abstract][Full Text] [Related]
38. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
[TBL] [Abstract][Full Text] [Related]
39. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
Takada Y; Otsuka M; Todoroki T; Fukao K
Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
[TBL] [Abstract][Full Text] [Related]
40. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]